Evaluation of the effect of food on the pharmacokinetics of avitriptan

Biopharmaceutics and Drug Disposition

Volumn 19, Issue 6, 1998, Pages 381-394

  Marathe, P H ^a   Greene, D S ^a   Kollia, G D ^a   Barbhaiya, R H ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Avitriptan; Bioavailability; Food effect

Indexed keywords

AVITRIPTAN;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EXCRETION; FEMALE; FOOD; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LIPID DIET; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; STOMACH PH; URINARY EXCRETION;

AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; FEMALE; FOOD-DRUG INTERACTIONS; GASTRIC EMPTYING; HUMANS; HYDROGEN-ION CONCENTRATION; INDOLES; MALE; POSTPRANDIAL PERIOD; RANITIDINE; SEROTONIN AGONISTS; SULFONAMIDES; TRYPTAMINES; VASOCONSTRICTOR AGENTS;

EID: 0031822388     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199809)19:6<381::AID-BDD118>3.0.CO;2-J     Document Type: Article

References (24)

1. R.A. Myers, N.S. Sarbin, M.A. Kapin and F.D. Yocca, Modulation of feline cephalic arterio-venous shunting and systemic hemodynamics following administration of BMS-180048 and sumatriptan. FASEB J. Abstr., 9, A23 (1995).
2. F.D. Yocca, J.A. Gylys, J. Buchanan and R.A. Myers, Effect of BMS-180048 on carotid arterial blood flow and arteriovenous blood oxygen content in the anesthetized dog. FASEB J. Abstr., 9, A23 (1995).
3. H.L. Wiener, G.P. Thalody and F.D. Yocca, Kinetic characterization of the responses to BMS-180048, a novel antimigraine agent in cerebral blood vessels. FASEB J. Abstr., 9, A347 (1995).
4. N.S. Sarbin, J.A. Gylys, L.G. Iben, C.D. Mahle, D.G. Izzarelli, E.M. Parker, J.W. Noonan, A.D. Williams, D.W. Smith, E. Hamel and F.D. Yocca, The receptor binding and vascular in vitro pharmacological profile of BMS 180048. FASEB J. Abstr., 9, A347 (1995).
5. P.H. Marathe, D. S. Greene and R.H. Barbhaiya, Disposition of [UC]BMS 180048 in rats. Pharm. Res., 13, S-497 (1996).
6. P.H. Marathe, D.S. Greene, J.S. Lee and R.H. Barbhaiya, Assessment of effect of food, gender and intra-subject variability in the pharmacokinetics of avitriptan. Biopharm. Drug Dispos., 19, 153-157 (1998).
7. P.H. Marathe, K.D. Larkin, G.F. Duncan, D.S. Greene and R.H. Barbhaiya, Determination of a novel indolylpiperazine anti-migraine agent in rat, monkey, mouse and rabbit plasma by high-performance liquid chromatography with electrochemical detection. J. Chromatogr., 678, 269-277 (1996).
8. E. Brewer, P. Bennett, M. Latham, J. Henion and P. Marathe, Quantitative determination of BMS-180048, BMS-184273, BMS-203518 and BMY 41728 in plasma using ion spray LC/MS/MS. Pharm. Res., 13, S-53 (1996).
9. R.C. Littell, R.J. Freund and P.C. Spector, SAS® System for Linear Models, 3rd edn, SAS Institute Inc., Cary, NC, 1991.
10. W.C. Shyu, C.A. Knupp, K.A. Pittman, L. Dunkle and R.H. Barbhaiya, Food induced reduction in bioavailability of didanosine. Clin. Pharmacol Ther., 50, 503-507 (1991).
11. D.P. Reitberg, S.J. Love, G.T. Quercia and M.A. Zinny, Effect of food on nifedipine pharmacokinetics. Clin. Pharmacol. Ther., 42, 72-75 (1987).
12. B. Delhotal-Landes, B. Flouvat, M. S. Boulin, I. Karpouzas and J. Prinseau, Influence of food on the absorption of theophylline administered in the form of sustained release tablet and microgranules. Biopharm. Drug Dispos., 9, 19-29 (1988).
13. H. Liedholm, E. Wahlin-Boll and A. Melander, Mechanisms and variations in the food effect on propranolol bioavailability. Eur. J. Clin. Pharmacol., 38, 469-475 (1990).
14. P.C. Welling, Influence of food and diet on gastrointestinal drug absorption, a review. J. Pharmacokin. Biopharm., 5, 291-334 (1977).
15. P.G. Welling, Effects of food on drug absorption. Pharmacol. Ther., 43, 425-441 (1989).
16. D.R. Doose, F.L. Minn, S. Stellar and R.K. Nayak, Effects of meals and meal composition on the bioavailability of fenretinide. J. Clin. Pharmacol., 32, 1089-1095 (1992).
17. M.N. Gai, A.M. Thielemann and A. Arancibia, Evaluation of the effects of different kinds of foods on the bioavailability of a sustained release theophylline tablet. Int. J. Clin. Pharmacol. Ther. Toxicol., 31, 547-552 (1993).
18. R.C. Spiller, Feedforward and feedback control mechanisms in the gut. Dig. Dis. 8, 189-205 (1990).
19. O. Johansson, E. Wahlin-Boll, T. Lindberg and A. Melander, Opposite effects of carbohydrate and protein on phenytoin absorption in man. Drug-Nutrient Interact., 2, 139-144 (1983).
20. K.E. Anderson, Influences of diet and nutrition on clinical pharmacokinetics. Clin. Pharmacokinet., 14, 325-346 (1988).
21. H. Minami and R.W. McCallum, The physiology and pathophysiology of gastric emptying in humans. Gastroenterology, 86, 1592-1610 (1984).
22. G.S. Hughes, D.L. Heald, K.B. Barker, R.K. Patel, C.R. Spillers, K.C. Watts, D.H. Batts and A.R. Euler, The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil. Clin. Pharm. Ther., 46, 674-685 (1989).
23. 2-antagonist drug interactions in perspective: Mechanistic concepts and clinical implications. Am. J. Med., 77(Suppl 5B), 57-84 (1984).
24. 14C]avitriptan in rats and humans. Drug Metab. Dispos., 25, 881-888 (1997).